Wird geladen...
Treatment of relapsed extranodal natural killer/T-cell lymphoma with bortezomib plus fludarabine
Extranodal NK/T cell lymphoma (ENKL) is a rare entity, associated with an aggressive clinical behavior and poor prognosis. The optimal treatment strategies, particularly for relapsed patients, have not been clearly determined. A 40-year-old female ENKL patient with orbital involvement as the first p...
Gespeichert in:
| Veröffentlicht in: | Mol Clin Oncol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
D.A. Spandidos
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5574062/ https://ncbi.nlm.nih.gov/pubmed/28855986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1364 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|